Published online February 1, 2006
PEDIATRICS Vol. 117 No. 2 February 2006, pp. 486-496 (doi:10.1542/peds.2005-0340)
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szilagyi, P. G.
Right arrow Articles by Yoos, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szilagyi, P. G.
Right arrow Articles by Yoos, H. L.
Related Collections
Right arrow Asthma
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SPECIAL ARTICLE

Improved Asthma Care After Enrollment in the State Children's Health Insurance Program in New York

Peter G. Szilagyi, MD, MPHa,b, Andrew W. Dick, PhDb, Jonathan D. Klein, MD, MPHa,b, Laura P. Shone, MSW, DrPHa, Jack Zwanziger, PhDc, Alina Bajorska, MSb and H. Lorrie Yoos, RN, PhDd

a Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York
b Department of Community and Preventive Medicine and Strong Children's Research Center, University of Rochester School of Medicine and Dentistry, Rochester, New York
d the School of Nursing, University of Rochester School of Medicine and Dentistry, Rochester, New York
c School of Public Health, University of Illinois at Chicago, Chicago, Illinois


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
BACKGROUND. Uninsured children with asthma are known to face barriers to asthma care, but little is known about the impact of health insurance on asthma care.

OBJECTIVES. We sought to assess the impact of New York's State Children's Health Insurance Program (SCHIP) on health care for children with asthma.

DESIGN. Parents of a stratified random sample of new enrollees in New York's SCHIP were interviewed by telephone shortly after enrollment (baseline, n = 2644 [74% of eligible children]) and 1 year later (follow-up, n = 2310 [87%]). Asthma was defined by parent report using questions based on National Heart, Lung, and Blood Institute criteria. A comparison group (n = 401) who enrolled in SCHIP 1 year later was interviewed as a test for secular trends.

MAIN OUTCOME MEASURES. Access (having a usual source of care [USC], unmet health needs, problems receiving acute asthma care), asthma-related medical visits, quality (continuity of care at the USC, problems receiving chronic asthma care, use of antiinflammatory medications), and asthma outcomes (change in asthma care or severity) were the main outcome measures used. Bivariate and multivariate analyses compared measures at baseline (year before SCHIP) versus follow-up (year during SCHIP).

RESULTS. Three-hundred eighty-three children (14%) had asthma at baseline, and 364 had asthma at follow-up (16%). No secular trends were detected between the baseline study group and the comparison group. After enrollment in SCHIP, improvements were noted in access: lacking a USC (decrease from 5% to 1%), unmet health needs (48% to 21%), and problems getting to the USC for asthma (13 to 4%). Children had fewer asthma-related attacks and medical visits after SCHIP (mean number of attacks: 9.5 to 3.8: mean number of asthma visits: 3.0 to 1.5; hospitalizations: 11% to 3%). Quality of asthma care improved for general measures (most/all visits to USC: 53% to 94%; mean rating of provider: 7.9 to 8.8 of 10) and asthma-specific measures (problems getting to the USC for asthma care when child was well: 13% to 1%). More than two thirds of the parents at follow-up reported that both quality of asthma care and asthma severity were "better or much better" than at baseline, generally because of insurance coverage or lower costs of medications and medical care.

CONCLUSIONS. Enrollment in New York's SCHIP was associated with improvements in access to asthma care, quality of asthma care, and asthma-specific outcomes. These findings suggest that health insurance improves the health of children with asthma.

Key Words: SCHIP • health insurance • children • asthma

Abbreviations: NHLBI—National Heart, Lung, and Blood Institute • SCHIP—State Children's Health Insurance Program • FPL—federal poverty level • USC—usual source of care • ED—emergency department

Asthma is the most prevalent chronic medical condition of childhood1,2 and affects >6 million US children annually3 with substantial morbidity4–6 and cost.7 Low-income and minority children have the greatest morbidity from asthma8–13 and are less likely to receive asthma care6 that prevents asthma exacerbations.12,14–18

Health care–system, provider, and family barriers to asthma care have been identified.19 Health care–system barriers include lack of health insurance,20–22 primary care,22 care coordination,23 or acute care services24,25 and the high cost of asthma medications and services.26–29 Health care–provider factors include lack of recognition of the child's asthma severity30,31 and suboptimal compliance with recommended guidelines for asthma management.32–37 Family-based barriers38 include confusion about asthma symptoms39,40 and therapies.41–44

Recent models of care management for chronic disease45–47 have pointed out that all 3 components (system, provider, and family) are important in improving outcomes among patients with chronic disease such as asthma. Most studies of childhood-asthma interventions have evaluated provider-level strategies48–55 or family-based interventions56; few have evaluated health care–system changes such as provision of health insurance. A study in the mid-1990s of a state pilot health insurance program for previously uninsured children noted some improvements but still suboptimal levels of access to asthma care after the provision of insurance coverage.57 At the time of that study, new childhood-asthma guidelines from the National Heart, Lung, and Blood Institute (NHLBI) were just being disseminated.58 Given recent improvements in our understanding of childhood asthma as well as widely distributed and measurable guidelines,59,60 it is now possible to better assess the degree to which provision of health insurance plays a role in improving childhood-asthma care.

The State Children's Health Insurance Program (SCHIP) provided a unique opportunity to examine these questions. SCHIP was enacted in 1997 as Title XXI of the Social Security Act61 to provide health insurance coverage to low-income children who are neither eligible for Medicaid nor covered by private health insurance. Studies of SCHIP have noted improved access to health care among the enrolled population.62–67 However, little is known about the impact of SCHIP on children with chronic diseases68 such as asthma. This study assessed the impact of New York's SCHIP on access, utilization of services, quality of care, and asthma-related outcomes among children with asthma.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
This asthma study was part of a larger evaluation of children who enrolled in New York's SCHIP; overall study methods are published elsewhere.66,67

Setting: New York's SCHIP
In 2001, New York had 590000 SCHIP enrollees (18% of US SCHIP enrollees).69 New York's SCHIP was provided by 32 managed care plans.70,71 Children were eligible if they were 0 to 18 years old, at or below 230% of the federal poverty level (FPL), New York residents, not covered by other insurance, and not eligible for Medicaid. Monthly premiums varied by income, from none (for those at <160% of the FPL) to $9 to $15 per child (family maximum of $45 for ≥3 children). A few families at >230% of the FPL purchased SCHIP for the full monthly premium. The state-defined benefit package included ambulatory, emergency, inpatient, and prescription medications, which are similar to benefits of commercial plans but less comprehensive than those available through New York's Medicaid plan.72 Coverage of nebulizer machines and spacers varied by insurer.

Study Design
We used a baseline versus follow-up–cohort design.66,67 We interviewed parents of New York's SCHIP enrollees shortly after enrollment (baseline interview) in 2001 and again 13 months after enrollment (follow-up interview). The baseline interviews reflected the child's experience in the 1-year period before SCHIP, and the follow-up interviews reflected the first year during SCHIP enrollment.

Study Subjects
New York's SCHIP administrative files were analyzed to identify new enrollees. A stratified random sample (1 child per family) was selected from 4 geographic regions, 3 age groups (0–5, 6–11, and 12–18 years), and 3 race/ethnicity groups based on parent self-report (white non-Hispanic, black non-Hispanic, and Hispanic; other groups were excluded).73 The data were weighted to account for this complex sampling design so that estimates were representative of SCHIP enrollees statewide.

We also interviewed parents of a separate comparison group of children66 who enrolled in SCHIP 1 year after the study group enrolled. This comparison group comprised a simple random sample of SCHIP enrollees throughout New York State; it was designed to test for secular trends because their pre-SCHIP period was identical to the SCHIP time period for the study group. During the study time period, there were no changes in national asthma guidelines.

Telephone Interviews
The National Opinion Research Center,74 using Computer Assisted Technology, Inc75 (Buffalo Grove, IL) conducted telephone interviews. Baseline interviews were conducted between March 15, 2001, and September 15, 2001, and follow-up interviews were conducted between December 1, 2001, and May 4, 2002. Interviews were conducted in English and Spanish, day and evening, 7 days per week.

General Dependent Measures
Key questions were obtained from standard instruments or developed for the study. Demographic measures included patient age, gender, race/ethnicity, single-parent household, family income, and parent education and employment. Overall health status was measured as excellent, good, fair, or poor.76 Prior health insurance was assessed as the number of months that the child was insured during the year before enrollment and the type of insurance that was held before SCHIP (private, public, none). Access measures included the presence of a usual source of care (USC), accessibility of the USC (4 measures77), and overall and specific unmet health care needs. Utilization measures involved use of health services during the relevant years (before and during SCHIP) for emergency department (ED), outpatient, or hospital care. Quality measures included use of the USC for none, some, most, or all care (a measure of continuity) and parents' ratings of specific aspects of health care and their primary provider using Consumer Assessment of Health Plans items.77

Asthma-Specific Measures
Because there is no gold-standard set of questions for identifying children with asthma, we adapted 5 questions from NHLBI criteria59 that have been used in other studies.6,30,31,57 These questions were asked at both baseline and follow-up, because children could "grow into" or "grow out of" asthma over the 2-year study time frame. Questions pertained to either the 12-month period before (baseline) or after enrollment (follow-up). Parents were asked (1) whether a physician said the child has asthma and, for times other than when the child had a cold, whether the child had (2) wheezing or whistling in the chest, (3) chest sounding wheezy during or after exercise, (4) waking from sleep because of coughing, wheezing, or trouble breathing, and (5) wheezing severe enough to limit speech. A positive response to any question identified the child as having asthma and invoked a series of asthma-related questions.

For each time period, parents were asked 3 additional severity questions based on the 3 NHLBI criteria30,31,59 to classify the child's asthma as "mild intermittent" or "mild persistent to severe" (hereafter designated "mild" or "moderate/severe"): (1) frequency of wheezing, coughing, or shortness of breath during a typical week or month; (2) limitation of physical activity resulting from asthma; and (3) nighttime awakening from sleep because of coughing, wheezing, or trouble breathing. These questions were used for asthma-severity classification only.

Asthma-related–dependent measures included (1) access (problems getting care or obtaining medications during an asthma attack and specific reasons for these problems), (2) utilization (hospitalizations and visits for asthma attacks), (3) quality (problems getting asthma chronic-care checkups or medications, use of antiinflammatory medications or asthma action plans), and (4) outcomes (change in severity of the child's asthma and the quality of care for asthma between the 2 years). The last 2 questions were asked only at follow-up. All other questions were asked identically at baseline and follow-up.

Analyses
For bivariate and multivariate analyses, we restricted the analyses to children with asthma.

Comparisons
We present analyses that included all children who were identified as having asthma at baseline and all children who were identified as having asthma at follow-up regardless of their asthma status at the other interview. This analytic strategy was selected because it reflects the reality that children can grow into or out of asthma (or into or out of "moderate/severe asthma") and that preexisting yet undiagnosed asthma could be newly diagnosed after obtaining insurance. It best represents the population of SCHIP enrollees with asthma at either time period. We also compared baseline versus follow-up measures by limiting analyses to (1) those children with asthma who were identified at both baseline and follow-up and (2) the cohort of children who were identified at baseline only. Although each method has different potential strengths and weaknesses, results from all 3 methods were nearly identical.

We compared antiinflammatory medication use and provision of a written asthma action plan before versus during SCHIP coverage. These measures were assessed for all children with asthma (including all levels of asthma severity reported at the time of interview), although at any point in time only children with moderate/severe asthma should have these interventions. We did this to minimize the bias in our estimates of the effect of SCHIP on these measures. If asthma care improved as a result of SCHIP and this improvement left fewer children with moderate/severe asthma symptoms during SCHIP coverage, analyses that included only children with moderate/severe asthma would generate selection biases. By considering all children with asthma, we avoid this concern. Also, our severity classification may not correlate precisely with criteria used by physicians in implementing antiinflammatory medicines or action plans, resulting in misclassification of who should have been prescribed these interventions.

Statistics
In all analyses, we used sample weights to obtain estimated means (and odds ratios) for children with asthma. We used Stata 8.278 to account for the complex sampling design.

We first summarized baseline demographics, health characteristics, and insurance measures (baseline survey) for children with asthma in the SCHIP population. Subsequent analyses compared before SCHIP versus during SCHIP using survey-design–based F tests and t tests. All results shown in the tables are for New York's SCHIP population with asthma.

To assess whether bivariate results of key outcomes were affected by confounding demographic and prior insurance variables, we estimated multivariate logistic-regression models of key unmet needs, continuity at the USC, and asthma-specific quality measures, controlling for the demographic characteristics and prior insurance status that are shown in Table 1. We included an identifier for moderate/severe versus mild asthma and calculated adjusted odds ratios and confidence intervals for follow-up versus baseline separately for each subgroup. We then compared these adjusted results with the unadjusted bivariate results. Generalized estimating equations79 were used to estimate logistic population-averaged models and to account for the correlation between baseline and follow-up responses for same child.


View this table:
[in this window]
[in a new window]
  		TABLE 1 Demographic and Health Characteristics of the SCHIP Population With Asthma

 
Study Approval
The University of Rochester Research Subjects Review Board approved the study.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Contact and Completion Rates at Baseline
Of 9101 index children in the sample frame, 1808 (19.9%) were unable to be located; successful contact was made with 7293 (80.1%). Of these, 4528 (62.1%) were ineligible because (1) study enrollment was full for that combination of race/ethnicity, age, and region of residence in New York State (the vast majority of ineligibles), (2) the child had moved out of state, (3) the child was reported by the parent to not be enrolled in SCHIP, or (4) the child had died. After exclusions, 3658 (50.2%) of the 7293 who were contacted were eligible. Of those, 957 (26.6%) refused and 2701 (73.8%) agreed to participate. Parents of 2644 children completed the baseline interview, and parents of 2310 (87%) children completed the follow-up interview.

Parents of 401 children completed the comparison-group interview.

Prevalence of Asthma
At baseline, 383 (14%) of 2644 children had asthma. Of these, 155 (40%) had moderate/severe asthma. At follow-up, 364 (16%) of 2310 children had asthma, including 126 (35%) with moderate/severe asthma. Forty-nine children interviewed at baseline were lost to follow-up (and excluded). The final samples comprised 334 at baseline and 364 at follow-up. Altogether, we analyzed 472 children with asthma who were identified at either baseline or follow-up. The prevalence of asthma was not statistically different between the baseline and follow-up periods.

Comparison Group Versus Study Group
Key measures for the pre-SCHIP period were compared for the study group (n = 2644) versus the comparison group (n = 401) to assess potential secular trends. Of 34 measures tested including demographics, access, unmet needs, utilization of outpatient services, and quality of care, statistically significant differences were noted for only 3 measures (results are available from the corresponding author). There was no statistical difference in asthma prevalence: 72 comparison-group children (17.9%) had asthma. We also compared 23 measures of access, unmet needs, and utilization for children with asthma in the baseline study group (n = 334) versus the comparison group (n = 72). There were no significant differences between the 2 groups. These results suggest that there were no major secular trends during this 1-year time span.

Demographic Characteristics of SCHIP Enrollees With Asthma
SCHIP enrollees with asthma were from families with low income, and many children were from minority, single-parent, working households (Table 1). Many children had poor health status.

Access and Utilization of Health Care Among Children With Asthma
The proportion of children with asthma who had no USC (Table 2) decreased during SCHIP coverage from 5% to 1%. It is notable that 45% of the children changed their USC after enrollment in SCHIP. Two indicators of accessibility improved after SCHIP enrollment: travel time of ≥30 minutes and difficulty getting an appointment at the USC.


View this table:
[in this window]
[in a new window]
  		TABLE 2 Access and Accessibility to the USC Before and During SCHIP Coverage

 
Table 3 shows the percentage of children with asthma whose parent reported unmet needs. The proportion of children who had a specific need for health care did not change after enrollment in SCHIP. However, the proportion with an unmet need dropped substantially during SCHIP for any health care and also for specialty care, acute care, prescription medications, and ED care.


View this table:
[in this window]
[in a new window]
  		TABLE 3 Health Care Needs and Unmet Needs Before and During SCHIP Coverage

 
Table 4 shows results for parent-reported utilization of health care before and during SCHIP coverage. For general pediatric care, preventive visits increased and use of the ED and outpatient services were similar before and during SCHIP. For asthma-specific care, the number of asthma attacks and rate of hospitalizations and ED visits were all lower during SCHIP compared with before SCHIP. Utilization patterns did not differ by age group.


View this table:
[in this window]
[in a new window]
  		TABLE 4 Utilization of Health Care Before and During SCHIP Coverage

 
Quality of Care Before and During SCHIP Coverage Among Children With Asthma
The proportion of children who made most or all of their outpatient visits to their USC (Table 5) increased from 53% to 94% (P < .001), and the proportion who made none of their visits to their USC declined from 40% to 1% (P < .001). The mean rating of the USC provider improved during SCHIP coverage (P = .003), as did 3 of 4 specific Consumer Assessment of Health Plans measures that reflected the quality of interpersonal care received. Parents' overall rating of their child's health status did not change after enrollment in SCHIP; however, fewer parents worried about their child's health after enrollment. Two asthma-specific measures improved: fewer children had trouble getting to the USC during an asthma attack, and fewer had trouble getting to the USC for discussion of asthma when the child was well. Receipt of antiinflammatory medicines was 19.0% before SCHIP and 38.5% during SCHIP (P = .088); however, the sample size for this variable was limited. Receipt of asthma action plans did not seem to increase during SCHIP.


View this table:
[in this window]
[in a new window]
  		TABLE 5 Quality-of-Care Measures Before and During SCHIP Coverage

 
At the follow-up interview only, we asked parents whether their child's asthma severity had changed. Parents stated that their child's asthma was much better (59%), better (14%), the same (26%), worse (0.9%), or much worse (0%). Regarding overall quality of asthma care, the parents stated that quality was much better (50%), better (13%), the same (35%), worse (1.5%), or much worse (0%). When parents indicated the reasons for change in asthma severity or quality of asthma care, 2 major reasons for improvements were that their child "now has medicines" or "now has medical care" (mentioned by 70% for reduced asthma severity and 86% for improved quality of asthma care).

Multivariate Analyses
None of the results from the multivariate analyses were substantively different from those of the bivariate analyses, which suggests that the changes observed after SCHIP enrollment were not explained by differences in other variables. For example, we calculated the unadjusted and adjusted (for the variables listed in Table 1) odds ratios for having "problems getting asthma medications" (from Table 6) during SCHIP versus before SCHIP separately for children uninsured and insured before SCHIP. For previously uninsured children with severe asthma, the unadjusted and adjusted odds ratios were 0.05 (P < .001) and 0.04 (P = .001), respectively, and for previously insured children, the odds ratios were 0.09 (P < .05) and 0.1 (P < .05), respectively. Similar findings were noted for children with mild asthma, with similar odds ratios for unadjusted and adjusted analyses (if uninsured: 0.16 and 0.12, respectively [P < .01]; if insured: 0.32 and 0.29, respectively [P > .05]). This result suggests that (1) controlling for child characteristics did not affect the findings, and the effect of SCHIP was significant and stronger for uninsured children; and (2) the SCHIP effect was greater for children with severe asthma who also had more problems at baseline.


View this table:
[in this window]
[in a new window]
  		TABLE 6 Access Measures by Pre-SCHIP Insurance Status

 
Subgroup Analysis by Prior Health Insurance
Table 6 shows key measures of access for those who were uninsured or insured before SCHIP coverage. Three findings are noted: First, during the year before SCHIP, previously uninsured children had poorer access to asthma care than did children who had health insurance. Second, uninsured children experienced greater gains in access to asthma care during SCHIP than did previously insured children. Third, during SCHIP, the levels of access were similar for children who had been previously uninsured versus insured. These findings reinforce the conclusion that improvements associated with SCHIP enrollment were a result of the provision of health insurance.


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Enrollment in New York's SCHIP was associated with improvements in access to care, reductions in unmet health care needs, reductions in asthma attacks and urgent care asthma-related visits, and improvements in quality of asthma care. Results were not affected by adjustments for other variables, and improvements were greatest among children who had been uninsured previously. These findings suggest that the improvements were a result of SCHIP coverage.

Impact of SCHIP on Children With Asthma
Asthma Prevalence
The prevalence of asthma in New York's SCHIP (14–16%) was at least as high as the prevalence in the general population. If enrollment in New York's SCHIP is representative, >500000 children with asthma are enrolled nationally in SCHIP, and SCHIP can play an important role in addressing health care needs of children with asthma.

Asthma Morbidity
The number of asthma attacks that are experienced by children was markedly reduced during SCHIP compared with before SCHIP coverage, as were urgent health care visits and asthma-related hospitalizations. The parents reported improvements in their child's asthma severity during SCHIP. Together, these findings strongly suggest that receipt of SCHIP coverage was associated with a reduction in asthma morbidity.

SCHIP and the Potential Role of the Medical Home
Although more than one third of SCHIP enrollees with asthma were insured before SCHIP and 95% already had a USC, their unmet needs were high before SCHIP, and asthma visits were scattered across health care sites. During SCHIP, the pattern of care changed. More than 90% of children made most or all visits to their USC, and unmet needs were far lower, which suggests that provision of health insurance may facilitate use of the USC as a "medical home"80 for children with asthma, providing more accessible and coordinated care by the primary care provider that does not usually require specialty, ED, or hospital care.81,82 Children had equivalent service needs before and during SCHIP, but more of these needs were addressed successfully during SCHIP. Most parents attributed reasons for these improvements to better access to health care or medications.

Mechanisms by Which SCHIP Seemed to Improve Asthma Care
Although our study was not designed to determine how health insurance improves asthma care, our findings shed light on possible mechanisms. Because 45% of children changed their USC after enrollment in SCHIP, we anticipated that this may be a major factor. However, neither our subgroup analysis nor multivariate analysis found that children whose USC changed experienced greater improvements in asthma measures than those who did not change their USC. Second, although there was an overall trend toward more use of antiinflammatory medications (from 19% before SCHIP to 39% during SCHIP), greater use of antiinflammatory medications by themselves did not explain the improved outcomes. More intensive interventions83,84 beyond simply providing health insurance are likely needed to ensure optimal use of antiinflammatory medications. We therefore suspect that multiple factors resulted in improved asthma care within the USC. These other factors85 include receipt of acute reliever asthma medications at the USC, improved compliance with medications that are covered under SCHIP, and education about asthma that leads to earlier recognition of symptoms or changes in the environment (such as reduced exposure to tobacco). The parents stated that overall insurance coverage for medicines and improved overall asthma-related care were the key factors.

Strengths and Limitations
Our study was based on parent self-report without verification by providers, claims data, or medical chart review. Nonetheless, for some sentinel events such as hospitalizations or ED visits, self-report has been found to have good validity.86,87 Second, we could not control for possible regression to the mean (eg, children with particularly poor access at baseline or high unmet needs may have been more likely to enroll in SCHIP, and their care may have improved even in the absence of SCHIP). Our finding that pre-SCHIP access (eg, having a USC or unmet needs) were better than rates reported for uninsured children nationally88 makes regression to the mean less likely. Third, although we did not find any evidence for secular trends by using our comparison-group sample, secular trends still may have affected the results. Fourth, although the second interview captured 87% of those who were interviewed initially and nonresponders seemed similar to responders on baseline measures, some bias may have occurred from loss to follow-up. Fifth, we included all children who completed both interviews, although only 36% of the SCHIP enrollees with asthma were insured for 12 months before SCHIP and one sixth had become uninsured by the time of the second interview. However, both of these factors result in conservative estimates of the effect of SCHIP coverage on the population. Finally, it is possible that some of the improvements noted could have been a result of the child's SCHIP coverage being provided by managed care plans and not solely to the provision of insurance.

External validity is limited in that we studied only 1 state, although New York had 18% of the nation's SCHIP population. We studied white, black, and Hispanic children and not children of other races. Our study also focused on children who enrolled in SCHIP rather than children who were eligible but not enrolled.89,90 Thus, our study findings may not be generalizable to the entire population of near-poor children nor to children on Medicaid.

Implications for Clinicians and Policy Makers
Clinicians should be aware that many children with asthma are enrolling in SCHIP; their baseline unmet needs are high and quality of asthma care is poor. Enrollment in SCHIP may result in greater reliance on the USC and less scattering of care, which would enhance the opportunity for care within a medical home. More intensive office-based interventions are needed to improve key quality measures such as receipt of antiinflammatory asthma medicines.

Health plans that administer SCHIP should note that broad benefits are important for parents, who cited being able to afford asthma medicines as a major reason for improved asthma care.

State and federal policy makers should note that SCHIP coverage seems to improve access to asthma-related services as well as asthma-specific quality and outcome measures. Provision of health insurance seems to change the pattern of utilization of health services for children with asthma (with greater reliance on the USC) yet without greater use of high-cost specialty, emergency, or hospital services. SCHIP contributes to substantial benefits in quality of care, reduced parental worry, and perhaps better functional health status.

In sum, this study suggests that provision of health insurance to low-income children with asthma improves their health care.


   ACKNOWLEDGMENTS
 
This study, which was supported by cooperative agreement HS10450, issued by the Agency for Healthcare Research and Quality was co-funded by the Agency for Healthcare Research and Quality, the David and Lucile Packard Foundation, and the Health Resources and Services Administration. Support was also provided by New York State Department of Health grant T016804.

We acknowledge Sally Findley, PhD, Mattie Irigoyen, MD, Cindy Brach, MPP, and Eugene Lewit, PhD, for their assistance. This study was part of the Child Health Insurance Research Initiative, the objective of which is to supply policy makers with information to improve access to and quality of health care for low-income children.68,91–93


   FOOTNOTES
 
Accepted Jun 15, 2005.

Address correspondence to Peter G. Szilagyi, MD, MPH, Department of Pediatrics, Box 632, Strong Memorial Hospital, 601 Elmwood Ave, Rochester, NY 14642. E-mail: peter_szilagyi{at}urmc.rochester.edu

The authors have indicated they have no financial relationships relevant to this article to disclose.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Newacheck PW, Budetti PP, Halfon N. Trends in activity-limiting chronic conditions among children. Am J Public Health. 1986;76 :178 –184[Abstract/Free Full Text]
  2. Adams PF, Marano MA. Current estimates from the national health interview survey, 1994. Vital Health Stat 10. 1995;(193 pt 1) :1 –260
  3. National Center for Health Statistics. Asthma prevalence, health care use and mortality,2002. Available at: www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm. Accessed February 1, 2005
  4. Ordonez GA, Phelan PD, Olinsky A, Robertson CF. Preventable factors in hospital admission for asthma. Arch Dis Child. 1998;78 :143 –147[Abstract/Free Full Text]
  5. Homer CJ, Szilagyi P, Rodewald L, et al. Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics. 1996;98 :18 –23[Abstract/Free Full Text]
  6. Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics. 2000;105(1 pt 3) :272 –276
  7. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999;104 :957 –963[CrossRef][Web of Science][Medline]
  8. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health. 1992;82 :59 –65[Abstract/Free Full Text]
  9. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. N Engl J Med. 1994;331 :1542 –1546[Abstract/Free Full Text]
  10. Targonski PV, Persky VW, Orris P, Addington W. Trends in asthma mortality among African Americans and whites in Chicago, 1968 through 1991. Am J Public Health. 1994;84 :1830 –1833[Abstract/Free Full Text]
  11. Weiss KB, Wagener DK. Changing patterns of asthma mortality: identifying target populations at high risk. JAMA. 1990;264 :1683 –1687[Abstract/Free Full Text]
  12. Weitzman M, Gortmaker S, Sobol A. Racial, social, and environmental risks for childhood asthma. Am J Dis Child. 1990;144 :1189 –1194[Abstract/Free Full Text]
  13. McConnochie K, Russo MJ, McBride JT, Szilagyi PG, Brooks AM, Roghmann KJ. Socioeconomic variation in asthma hospitalization: excess utilization or greater need? Pediatrics. 1999;103(6) . Available at: www.pediatrics.org/cgi/content/full/103/6/e75
  14. Diaz T, Sturm T, Matte T, et al. Medication use among children with asthma in East Harlem. Pediatrics. 2000;105 :1188 –1193[Abstract/Free Full Text]
  15. Kattan M, Mitchell H, Eggleston P, et al. Characteristics of inner-city children with asthma: the national cooperative inner-city asthma study. Pediatr Pulmonol. 1997;24 :253 –262[CrossRef][Web of Science][Medline]
  16. Eggleston PA, Malveaux FJ, Butz AM, et al. Medications used by children with asthma living in the inner city. Pediatrics. 1998;101 :349 –354[Abstract/Free Full Text]
  17. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates: a small area analysis in Boston. Chest. 1995;108 :28 –35[Abstract/Free Full Text]
  18. Warman KL, Silver EJ, McCourt MP, Stein REK. How does home management of asthma exacerbations by parents of inner-city children differ from NHLBI guideline recommendations? Pediatrics. 1999;103 :422 –427[Abstract/Free Full Text]
  19. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol. 2002;109 :S554 –S559[CrossRef][Web of Science][Medline]
  20. Lara M, Allen F, Lange L. Physician perceptions of barriers to care for inner-city Latino children with asthma. J Health Care Poor Underserved. 1999;10 :27 –44[Web of Science][Medline]
  21. Wood PR, Smith LA, Romero D, Bradshaw P, Wise PH, Chavkin W. Relationships between welfare status, health insurance status, and health and medical care among children with asthma. Am J Public Health. 2002;92 :1446 –1452[Abstract/Free Full Text]
  22. Sin DD, Svenson LW, Cowie RL, Man SF. Can universal access to health care eliminate health inequities between children of poor and nonpoor families? A case study of childhood asthma in Alberta. Chest. 2003;124 :51 –56[Abstract/Free Full Text]
  23. Szilagyi PG, Rodewald LE, Savageau J, Yoos L, Doane C. Improving influenza vaccination rates in children with asthma: a test of a computerized reminder system and an analysis of factors predicting vaccination compliance. Pediatrics. 1992;90 :871 –875[Abstract/Free Full Text]
  24. Crain EF, Kercsmar C, Weiss KB, Mitchell H, Lynn H. Reported difficulties in access to quality care for children with asthma in the inner city. Arch Pediatr Adolesc Med. 1998;152 :333 –339[Abstract/Free Full Text]
  25. Lara M, Duan N, Sherbourne C, Halfon N, Leibowitz A, Brook RH. Children's use of emergency departments for asthma: persistent barriers or acute need? J Asthma. 2003;40 :289 –299[CrossRef][Web of Science][Medline]
  26. Lewis CE, Lewis MA. Evaluation and implementation of self-management programs for children with asthma. J Allergy Clin Immunol. 1987;80 :498 –500[CrossRef][Web of Science][Medline]
  27. Grupp-Phelan J, Lozano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma. 2001;38 :363 –373[CrossRef][Web of Science][Medline]
  28. Barrett JC, Gallien E, Dunkin J, Ryan L. Managing asthma within the context of the rural family. Public Health Nurs. 2001;18 :385 –391[CrossRef][Web of Science][Medline]
  29. Warman KL, Jacobs AM, Silver EJ. If we prescribe it, will it come? Access to asthma equipment for Medicaid-insured children and adults in the Bronx, NY. Arch Pediatr Adolesc Med. 2002;156 :673 –677[Abstract/Free Full Text]
  30. Halterman JS, Kaczorowski JM, Yoos HL, et al. Providers underestimate symptom severity among urban children with asthma. Arch Pediatr Adolesc Med. 2002;156 :141 –146[Abstract/Free Full Text]
  31. Halterman JS, McConnochie KM, Conn KM, et al. A potential pitfall in provider assessments of the quality of asthma control. Ambul Pediatr. 2003;3 :102 –105[CrossRef][Web of Science][Medline]
  32. Finkelstein JA, Lozano P, Shulruff R, et al. Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics. 2000;106 :886 –896[Abstract/Free Full Text]
  33. Cabana MD, Rand CS, Becher OJ, Rubin HR. Reasons for pediatrician nonadherence to asthma guidelines. Arch Pediatr Adolesc Med. 2001;155 :1057 –1062[Abstract/Free Full Text]
  34. Finkelstein JA, Brown RW, Schneider LC, et al. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995;95 :389 –394[Abstract/Free Full Text]
  35. Lewis MA, Rachelefsky G, Lewis CE, Leake B, Richards W. The termination of a randomized clinical trial for poor Hispanic children. Arch Pediatr Adolesc Med. 1994;148 :364 –367[Abstract/Free Full Text]
  36. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the Asthma in America national population survey. J Allergy Clin Immunol. 2002;110 :58 –64[CrossRef][Web of Science][Medline]
  37. Boudreaux ED, Emond SD, Clark S, Camargo CA Jr; Multicenter Airway Research Collaboration Investigators. Race/ethnicity and asthma among children presenting to the emergency department: differences in disease severity and management. Pediatrics. 2003;111 (5). Available at: www.pediatrics.org/cgi/content/full/111/5/e615
  38. Mansour ME. Lanphear BP, DeWitt TG. Barriers to asthma care in urban children: parent perspectives. Pediatrics. 2000;106 :512 –519[Abstract/Free Full Text]
  39. Yoos HL, Kitzman H, McMullen A, Sidora K. Symptom perception in childhood asthma: how accurate are children and their parents? J Asthma. 2003;40 :27 –39[CrossRef][Web of Science][Medline]
  40. Halterman JS, Yoos HL, Sidora K, Kitzman H, McMullen A. Medication use and health care contacts among symptomatic children with asthma. Ambul Pediatr. 2001;1 :275 –279[CrossRef][Web of Science][Medline]
  41. Finkelstein JA, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med. 2002;156 :562 –567[Abstract/Free Full Text]
  42. Lieu TA, Lozano P, Finkelstein JA, et al. Racial/ethnic variation in asthma status and management practices among children in managed Medicaid. Pediatrics. 2002;109 :857 –865[Abstract/Free Full Text]
  43. Yoos HL, Kitzman H, McMullen A. Barriers to anti-inflammatory medication use in childhood asthma. Ambul Pediatr. 2003;3 :181 –190[CrossRef][Web of Science][Medline]
  44. Farber HJ, Capra AM, Finkelstein JA, et al. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma. 2003;40 :17 –25[CrossRef][Web of Science][Medline]
  45. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1 :2 –4[Medline]
  46. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care; translating evidence into action. Health Aff (Millwood). 2001;20 :64 –78[Abstract/Free Full Text]
  47. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model—part 2. JAMA. 2002;288 :1909 –1914[Abstract/Free Full Text]
  48. Wissow LS, Warshow M, Box J, Baker D. Case management and quality assurance to improve care of inner-city children with asthma. Am J Dis Child. 1988;142 :748 –752[Abstract/Free Full Text]
  49. Clark NM, Feldman CH, Evans D, Levison MJ, Wasilewski Y, Mellins RB. The impact of health education on frequency and cost of health care use by low income children with asthma. J Allergy Clin Immunol. 1986;78 :108 –115[CrossRef][Web of Science][Medline]
  50. Taggart VS, Zuckerman AE, Sly RM, et al. You can control asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns. 1991;17 :35 –47[CrossRef][Web of Science][Medline]
  51. Evans D, Mellins R, Lobach K, et al. Improving care for minority children with asthma: professional education in public health clinics. Pediatrics. 1997;99 :157 –164[Abstract/Free Full Text]
  52. Shields MC, Griffin KW, McNabb WL. The effect of a patient education program on emergency room use for inner-city children with asthma. Am J Public Health. 1990;80 :36 –38[Abstract/Free Full Text]
  53. Evans R, Gergen PJ, Mitchell H, et al. A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study. J Pediatr. 1999;135 :332 –338[CrossRef][Web of Science][Medline]
  54. Homer C, Susskind O, Alpert HR, et al. An evaluation of an innovative multimedia educational software program for asthma management: report of a randomized, controlled trial. Pediatrics. 2000;106 :210 –215[Abstract/Free Full Text]
  55. Halterman JS, Szilagyi PG, Yoos HL, et al. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Arch Pediatr Adolesc Med. 2004;158 :460 –467[Abstract/Free Full Text]
  56. Guendelman S, Meade K, Benson M, Chen YQ, Samuels S. Improving asthma outcomes and self-management behaviors of inner-city children: a randomized trial of the health buddy interactive device and an asthma diary. Arch Pediatr Adolesc Med. 2002;156 :114 –120[Abstract/Free Full Text]
  57. Szilagyi PG, Holl JL, Rodewald LE, et al. Evaluation of New York State's Child Health Plus: children who have asthma. Pediatrics. 2000;3(suppl E) :719 –727
  58. National Asthma Education Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services; 1991. DHHS Publication 91-3042
  59. National Asthma Education Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services; 1997. NIH Publication 97-4051
  60. National Asthma Education and Prevention Program Expert panel report 2: guidelines for the diagnosis and management of asthma: update on selected topics2002. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed January 18, 2005
  61. Children's Health Insurance Program, Pub L 105–34 (Revenue Reconciliation Act of 1997)
  62. Eisert S, Gabow P. Effect of child health insurance plan enrollment on the utilization of health care services by children using a public safety net system. Pediatrics. 2002;110 :940 –945[Abstract/Free Full Text]
  63. Slifkin RT, Freeman VA, Silberman P. Effect of the North Carolina State Children's Health Insurance Program on beneficiary access to care. Arch Pediatr Adolesc Med. 2002;156 :1223 –1229[Abstract/Free Full Text]
  64. Shenkman E, Steingraber H, Bono C. Florida KidCare program evaluation report, January 2002. Available at: www.ichp.ufl.edu/documents/KidCareEvaluationYear6_2004Data_FinalReport_06202005.pdf. Accessed January 18, 2005
  65. Youngblade LM, Col J, Shenkman EA. Health care use and charges for adolescents enrolled in a title XXI program. J Adolesc Health. 2002;30 :262 –272[CrossRef][Web of Science][Medline]
  66. Szilagyi PG, Dick AW, Klein JD, Shone LP, Zwanziger J, McInerny T. Improved access and quality of care after enrollment in the New York State Children's Health Insurance Program (SCHIP). Pediatrics. 2004;113(5) . Available at: www.pediatrics.org/cgi/content/full/113/5/e395
  67. Shone LP, Dick AW, Klein JD, Zwanziger J, Szilagyi PG. Reduction in racial and ethnic disparities after enrollment in the State Children's Health Insurance Program (SCHIP). Pediatrics. 2005;115(6) . Available at: www.pediatrics.org/cgi/content/full/115/6/e697
  68. Szilagyi PG, Shenkman E, Brach C, et al. Children with special health care needs enrolled in SCHIP: patient characteristics and health care needs. Pediatrics. 2003;112(6 pt 2) . Available at: www.pediatrics.org/cgi/content/full/112/6/SE1/e508
  69. Centers for Medicare and Medicaid Services. The State Children's Health Insurance Program annual enrollment report: federal fiscal year 2001—October 1, 2000–September 30, 2001. Available at: www.cms.hhs.gov/schip/enrollment/schip01.pdf. Accessed November 10, 2005
  70. Dick AW, Klein JD, Shone LP, Zwanziger J, Yu H, Szilagyi PG. The evolution of SCHIP in New York: changing program features and enrollee characteristics. Pediatrics. 2003;112(6 pt 2) . Available at: www.pediatrics.org/cgi/content/full/112/6/SE1/e542
  71. Trafton S, Shone LP, Zwanziger J, et al. Evolution of a children's health insurance program: Lessons from New York State's Child Health Plus. Pediatrics. 2000;105 :692 –696
  72. Szilagyi PG. Care of children with special health care needs. Future Child. 2003;13 :137 –151[Medline]
  73. Shone LP, Dick AW, Brach C, et al. The role of race and ethnicity in SCHIP in 4 states: are there baseline disparities, and what do they mean for SCHIP? Pediatrics. 2003;112(6 pt 2) . Available at: www.pediatrics.org/cgi/content/full/112/6/SE1/e521
  74. The National Opinion Research Center. Available at: www.norc.uchicago.edu/about/index.asp. Accessed January 18, 2005
  75. Computer Aided Technology, Inc. Available at: www.cati.com. Accessed January 18, 2005
  76. National Center for Health Statistics (NHIS). Health status, respondent-assessed. Available at: www.cdc.gov/nchs/datawh/nchsdefs/healthstatus.htm. Accessed January 18, 2005
  77. The Consumer Assessment of Health Plans. Available at: www.ahcpr.gov/qual/cahpsix.htm. Accessed January 18, 2005
  78. Stata Statistical Software [computer program]. Release 8.2. College Station, TX: Stata Corp; 2004
  79. Diggle PJ, Haegerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. 2nd Ed. New York, NY: Oxford University Press; 2002
  80. American Academy of Pediatrics. Medical home initiatives for children with special needs. Available at: www.medicalhomeinfo.org/index.html. Accessed January 18, 2005
  81. Szilagyi PG, Kemper KJ. Management of chronic childhood asthma in the primary care office. Pediatr Ann. 1999;28 :43 –52[Web of Science][Medline]
  82. Brooks AM, McBride JT. The asthma specialist: when and why to refer the pediatric patient. Pediatr Ann. 1999;28 :55 –62[Web of Science][Medline]
  83. Homer CJ. Asthma disease management. N Engl J Med. 1997;337 :1461 –1463[Free Full Text]
  84. Heinrich P, Homer CJ. Improving the care of children with asthma in pediatric practice: the HIPPO project. Helping Improve Pediatric Practice Outcomes. Pediatr Ann. 1999;28 :64 –72[Web of Science][Medline]
  85. Szilagyi PG. Childhood asthma: we can do better! Pediatr Ann. 1999;28 :16 –17[Web of Science][Medline]
  86. Harel Y, Overpeck MD, Jones DH, et al. The effects of recall on estimating annual nonfatal injury rates for children and adolescents. Am J Public Health. 1994;84 :599 –605[Abstract/Free Full Text]
  87. Pless CE, Pless IB. How well they remember: the accuracy of parent reports. Arch Pediatr Adolesc Med. 1995;149 :553 –558[Abstract/Free Full Text]
  88. Newacheck PW, Hung YY, Wright KK. Racial and ethnic disparities in access to care for children with special health care needs. Ambul Pediatr. 2002;2 :247 –254[CrossRef][Web of Science][Medline]
  89. Haley JM, Kenney GM. Why aren't more uninsured children enrolled in Medicaid or SCHIP? Available at: www.urban.org/Template.cfm?NavMenuID=24&template=/TaggedContent/ViewPublication.cfm&PublicationID=7233. Accessed January 18, 2005
  90. Holahan J, Dubay L, Kenney GM. Which children are still uninsured and why. Future Child. 2003;13 :55 –80[Medline]
  91. Agency for Healthcare Research and Quality. The Child Health Insurance Research Initiative (CHIRI). February 2001. Available at: www.ahrq.gov/chiri. Accessed January 18, 2005
  92. Agency for Health Care Policy and Research. Learning from SCHIP I and learning from SCHIP II. Available at: www.ahrq.gov/about/cods/codschip.htm. Accessed January 18, 2005
  93. Brach C, Lewit EM, VanLandeghem K, et al. Who's enrolled in SCHIP? Findings from the Child Health Insurance Research Initiative (CHIRI). Pediatrics. 2003;112(6 pt 2) . Available at: www.pediatrics.org/cgi/content/full/112/6/SE1/e499
PEDIATRICS (ISSN 1098-4275). ©2006 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
M. Genel, M. A. McCaffree, K. Hendricks, P. A. Dennery, W. W. Hay Jr, B. Stanton, P. G. Szilagyi, and R. R. Jenkins
A National Agenda for America's Children and Adolescents in 2008: Recommendations From the 15th Annual Public Policy Plenary Symposium, Annual Meeting of the Pediatric Academic Societies, May 3, 2008
Pediatrics, October 1, 2008; 122(4): 843 - 849.
[Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
G. M. Kenney
SCHIP Data: An Author Responds
Health Aff., July 1, 2008; 27(4): 1199 - 1199.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
W. J. Ungar, A. Kozyrskyj, M. Paterson, and F. Ahmad
Effect of Cost-Sharing on Use of Asthma Medication in Children
Arch Pediatr Adolesc Med, February 1, 2008; 162(2): 104 - 110.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. M. Clancy, J. P. Kiley, and K. B. Weiss
Eliminating Asthma Disparities Through Multistakeholder Partnerships
Chest, November 1, 2007; 132(5): 1422 - 1424.
[Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Child Health Financing
State Children's Health Insurance Program Achievements, Challenges, and Policy Recommendations
Pediatrics, June 1, 2007; 119(6): 1224 - 1228.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. D. Klein, L. P. Shone, P. G. Szilagyi, A. Bajorska, K. Wilson, and A. W. Dick
Impact of the State Children's Health Insurance Program on Adolescents in New York
Pediatrics, April 1, 2007; 119(4): e885 - e892.
[Abstract] [Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
G. Kenney and J. Yee
SCHIP At A Crossroads: Experiences To Date And Challenges Ahead
Health Aff., March 1, 2007; 26(2): 356 - 369.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. M. Butz, M. Tsoukleris, M. Donithan, V. D. Hsu, K. Mudd, I. H. Zuckerman, and M. E. Bollinger
Patterns of Inhaled Antiinflammatory Medication Use in Young Underserved Children With Asthma
Pediatrics, December 1, 2006; 118(6): 2504 - 2513.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szilagyi, P. G.
Right arrow Articles by Yoos, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szilagyi, P. G.
Right arrow Articles by Yoos, H. L.
Related Collections
Right arrow Asthma
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?